Homepage
Medication Guide
How to Use Inotuzumab ozogamicin (Besponsa)
Inotuzumab ozogamicin (Besponsa) is an antibody-drug conjugate targeting CD22, specifically indicated for the treatment of relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leu...
507
Thursday, November 27th, 2025, 09:17
What is Inotuzumab ozogamicin (Besponsa)?
Inotuzumab ozogamicin (Besponsa) is an antibody-drug conjugate (ADC) targeting CD22. It achieves targeted elimination of cancer cells by precisely acting on the CD22 antigen expressed on the surface o...
508
Thursday, November 27th, 2025, 09:11
How to Purchase Inotuzumab ozogamicin (Besponsa)?
Inotuzumab ozogamicin (Besponsa) is a CD22-targeted antibody-drug conjugate (ADC) specifically indicated for the treatment of relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic ...
510
Wednesday, November 26th, 2025, 11:50
Side Effects of Avelumab (Bavencio)
Avelumab (Bavencio) is a programmed death-ligand 1 (PD-L1) blocking antibody indicated for the treatment of metastatic Merkel cell carcinoma (MCC), locally advanced or metastatic urothelial carcinoma ...
512
Wednesday, November 26th, 2025, 11:42
What are the Precautions for Using Avelumab (Bavencio)?
Avelumab (Bavencio) is a next-generation programmed death-ligand 1 (PD-L1) blocking antibody that plays a crucial role in the treatment of advanced tumors. Administered via intravenous infusion, stric...
506
Wednesday, November 26th, 2025, 11:39
Dosage and Administration, Recommended Dosage of Avelumab (Bavencio)
Avelumab (Bavencio) is a programmed death-ligand 1 (PD-L1)-blocking monoclonal antibody approved for the treatment of various solid tumors.Dosage and Administration, Recommended Dosage of Avelumab (Ba...
506
Wednesday, November 26th, 2025, 11:37
What are the Indications of Avelumab (Bavencio)?
Avelumab (Bavencio) is an innovative programmed death-ligand 1 (PD-L1) blocking antibody that activates the human immune system to combat tumor cells. As a key representative of immune checkpoint inhi...
511
Wednesday, November 26th, 2025, 11:34
What are the Procurement Channels for Avelumab (Bavencio)?
Avelumab (Bavencio) is a humanized monoclonal antibody targeting PD-L1, approved globally for the treatment of solid tumors including metastatic Merkel cell carcinoma, locally advanced or metastatic u...
510
Wednesday, November 26th, 2025, 11:01
Side Effects of Relugolix (Orgovyx)
Relugolix (Orgovyx) is an oral gonadotropin-releasing hormone receptor antagonist indicated for the treatment of advanced prostate cancer. As a novel endocrine therapy, it exhibits significant efficac...
507
Wednesday, November 26th, 2025, 10:55
What are the Precautions for Using Relugolix (Orgovyx)?
Relugolix (Orgovyx) is a next-generation gonadotropin-releasing hormone receptor antagonist that provides an important treatment option for patients with advanced prostate cancer. As an orally adminis...
514
Wednesday, November 26th, 2025, 10:50
51 / 214
2139 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved